DATA SHEET MALARONE TABLETS and …
1 DATA SHEET MALARONE® TABLETS and MALARONE® JUNIOR TABLETS Presentation MALARONE tablets are round, biconvex, pink film coated tablets, engraved on one side with “GX CM3”.
Download DATA SHEET MALARONE TABLETS and …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
CHAPTER 98 SELENIUM - goldfrankstoxicology.com
www.goldfrankstoxicology.comChapter 98 Selenium 1317 peroxidase catalyses the reduction of hydrogen peroxide to water and oxidized glutathione (GSSG, or glutathione disulfide); the reaction occurs
Drug-Induced Hepatotoxicity: A Review
www.japsonline.comJournal of Applied Pharmaceutical Science 02 (05); 2012: 233-243 mitochondria occurred, indicating the loss of mitochondrial membrane potentials (one of the characteristics of …
DBL SODIUM THIOSULFATE INJECTION Name of …
www.medsafe.govt.nzOverdosage Clinical features Overdose of sodium thiosulfate during treatment of cyanide poisoning results in thiocyanate toxicity. Symptoms of thiocyanate toxicity may be seen at serum thiocyanate concentrations above 10 mg/100 mL
Table of Reported Drugs with Mitochondrial Toxicity
www.mitoaction.orgTable of Reported Drugs with Mitochondrial Toxicity Pharmacologic Category Toxin Action Symptoms 1. Anticonvulsants Valproate …
OECD GUIDELINE FOR THE TESTING OF CHEMICALS
www.oecd.org473 Adopted: 21st July 1997 1/10 OECD GUIDELINE FOR THE TESTING OF CHEMICALS In Vitro Mammalian Chromosome Aberration Test INTRODUCTION 1. The purpose of the in vitro chromosome aberration test is to identify agents that cause
HIV/AIDS Programme - who.int
www.who.intimportant: addendum to 2006 who guidelines on antiretroviral therapy for hiv infection in adults and adolescents new dosage recommendations for stavudine (d4t)